These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Adrenocorticotropin secretion by mouse pituitary tumor cells in culture: the role of Ca+2 in stimulated and somatostatin-inhibited secretion.
    Author: Richardson UI.
    Journal: Endocrinology; 1983 Jul; 113(1):62-8. PubMed ID: 6134615.
    Abstract:
    SRIF inhibits ACTH secretion by AtT20/D16v (D16) mouse pituitary cells stimulated by high (50 mM) extracellular concentrations of K+ or by divalent cation ionophores. Although stimulation of ACTH secretion by K+ requires extracellular Ca+2, the response is invariant over medium Ca+2 concentrations of 0.003-1 mM; with Ca+2 concentrations from 1-5 mM there is a dramatic amplification of the secretory response. SRIF at concentrations of 10(-8) M completely inhibits the secretory response to K+ at Ca+2 concentrations between 0.2 and 1 mM; with increasing medium Ca+2 above 1 mM there is a progressive attenuation of SRIF-inhibition. At concentrations of 5 mM, Ca+2 alone can serve as an ACTH secretagogue. The ionophore ionomycin stimulates ACTH secretion in a Ca+2-dependent manner with a half-maximal effect at 5 X 10(-6) M ionomycin. The secretory response to ionomycin and to X537A is inhibited by at least 50% by SRIF. The secretory response to K+ is accompanied by a rapid and sustained increase in 45Ca+2 uptake, whereas the ionophores ionomycin, X537A, and A23187 increase Ca+2 efflux. SRIF does not affect Ca+2 movement across D16 cell membranes in response to either K+ or ionophores. These results show that an increase in intracellular Ca+2 is an effective stimulus to ACTH secretion by D16 cells and inhibition of ACTH secretion by SRIF is not effected by interference with the stimulus-elicited increase in intracellular Ca+2.
    [Abstract] [Full Text] [Related] [New Search]